SCHEMBL203238

SCHEMBL203238

CC1CCC(C(C)C)C(C(COC(=O)c2ccccc2)(COC(=O)c2ccccc2)C2CC(C)CCC2C(C)C)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 3/20 0.49
MAPK1 P28482 1/20 0.46
HIF1A Q16665 1/20 0.46
ALDH1A1 P00352 2/20 0.45
HPGD P15428 1/20 0.45
KCNA5 P22460 1/20 0.42
LMNA P02545 1/20 0.42
NPSR1 Q6W5P4 2/20 0.41
MAPT P10636 1/20 0.41
TSHR P16473 1/20 0.41
TRPV1 Q8NER1 3/20 0.41
P2RX4 Q99571 1/20 0.41
MEN1 O00255 1/20 0.40
NTSR1 P30989 1/20 0.40
KMT2A Q03164 1/20 0.40
HTR1A P08908 1/20 0.40
CYP2D6 P10635 1/20 0.40
SCN1A P35498 1/20 0.40
SLC6A3 Q01959 1/20 0.40
SCN5A Q14524 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene Glycol SCHEMBL203237 0.96 TRPM8 (0.46) TRPM8MAPK1HIF1AALDH1A1HPGD
Benzoic Acid SCHEMBL203239 0.80 TRPM8 (0.47) TRPM8ALDH1A1HPGDKCNA5LMNA
Menthol SCHEMBL28354486 0.78 TRPM8 (0.51) TRPM8ALDH1A1HPGDKCNA5LMNA
SCHEMBL15433966 0.78 TRPM8 (0.49) TRPM8MAPK1ALDH1A1HPGDKCNA5
Menthyl Benzoate SCHEMBL3885473 0.76 ALDH1A1 (0.69) TRPM8MAPK1ALDH1A1HPGDLMNA
Menthyl Benzoate SCHEMBL17407563 0.76 ALDH1A1 (0.69) TRPM8MAPK1ALDH1A1HPGDLMNA
Menthyl Benzoate SCHEMBL18708099 0.76 ALDH1A1 (0.69) TRPM8MAPK1ALDH1A1HPGDLMNA
Menthyl Benzoate SCHEMBL15498193 0.76 ALDH1A1 (0.69) TRPM8MAPK1ALDH1A1HPGDLMNA
Benzoic Acid 1-(3-Methyl)Butyl Ester SCHEMBL28354549 0.75 TRPM8 (0.48) TRPM8MAPK1ALDH1A1HPGDKCNA5
SCHEMBL9292733 0.75 TRPM8 (0.47) TRPM8MAPK1ALDH1A1HPGDKCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088872-B2 Procatalyst composition including silyl ester internal donor and method DOW GLOBAL TECHNOLOGIES LLC (US) 2012-01-03 US disclosed
EP-2350144-A1 PROCATALYST COMPOSITION INCLUDING SILYL ESTER INTERNAL DONOR AND METHOD Dow Global Technologies LLC (US) 2011-08-03 EP disclosed
WO-2010065361-A1 PROCATALYST COMPOSITION INCLUDING SILYL ESTER INTERNAL DONOR AND METHOD DOW GLOBAL TECHNOLOGIES INC. (US) 2010-06-10 WO disclosed
US-20100130709-A1 Procatalyst Composition Including Silyl Ester Internal Donor and Method W. R. GRACE & CO.-CONN. 2010-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130709-A1 Procatalyst Composition Including Silyl Ester Internal Donor and Method GNE, NANS, ELANE TRPM8 4579/4885MAPK1 2989/4885HIF1A 4238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.